Back
Freeport-McMoRan Vs. Monopar Therapeutics Industry Stock Comparison
Buy
57
FCX
Freeport-McMoRan
Last Price:
$42.21
Seasonality Move:
-0.68%
Sell
39
MNPR
Monopar Therapeutics
Last Price:
$34.85
Seasonality Move:
-27.37%
Buy
57
Freeport-McMoRan (FCX)
is a Buy
Is Freeport-McMoRan a Buy, Sell or Hold?
-
The current Freeport-McMoRan [FCX] share price is $42.19. The Score for FCX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
FCX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $34.51. The Score for MNPR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FCX Stock Price Chart
What is Freeport-McMoRan's stock price today?
-
The Freeport-McMoRan share price today is $42.19Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCX is experiencing slight selling pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $34.51Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.
FCX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.24 | Buy |
Relative Strength Index (14 RSI): | 67.08 | Buy |
Chaikin Money Flow: | -443053 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.79 - 40.71) | Buy |
Bollinger Bands (100): | (34.98 - 40.3) | Buy |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.86 | Sell |
Relative Strength Index (14 RSI): | 46.76 | Sell |
Chaikin Money Flow: | -2328 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.05 - 38.67) | Sell |
Bollinger Bands (100): | (31.85 - 43.25) | Sell |
FCX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.93 | Buy |
20-day SMA: | 39.6 | Buy |
50-day SMA: | 36.97 | Buy |
200-day SMA: | 40.89 | Buy |
8-day EMA: | 41.14 | Buy |
20-day EMA: | 39.81 | Buy |
50-day EMA: | 38.48 | Buy |
200-day EMA: | 40.04 | Buy |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.21 | Buy |
20-day SMA: | 35.08 | Sell |
50-day SMA: | 37.01 | Sell |
200-day SMA: | 25.73 | Buy |
8-day EMA: | 34.88 | Sell |
20-day EMA: | 35.47 | Sell |
50-day EMA: | 36.28 | Sell |
200-day EMA: | 27.84 | Buy |
Freeport-McMoRan Earnings Growth & FCX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.07 per share, an increase this year of $0.20 per share, and an increase next year of $0.54 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.39 per share, and an increase next year of $0.11 per share.
Freeport-McMoRan Technical Analysis
May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |